Our top pick for
Kraton Corporation is a chemicals business based in the US. Kraton Corporation shares (KRA) are listed on the NYSE and all prices are listed in US Dollars. Kraton Corporation employs 1,751 staff and has a trailing 12-month revenue of around $2 billion.
|Latest market close||$46.49|
|52-week range||$45.10 - $46.74|
|50-day moving average||$46.27|
|200-day moving average||$42.82|
|Wall St. target price||$46.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$5.21|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-09-20)||N/A|
|1 month (2022-08-28)||N/A|
|3 months (2022-06-27)||N/A|
|6 months (2022-03-28)||N/A|
|1 year (2021-10-01)||1.88%|
|2 years (2020-10-01)||163.55%|
|3 years (2019-10-01)||45.69%|
|5 years (2017-09-29)||14.96%|
Valuing Kraton Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Kraton Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Kraton Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Kraton Corporation shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Kraton Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.25. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Kraton Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Kraton Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $387.1 million.
The EBITDA is a measure of a Kraton Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2 billion|
|Operating margin TTM||13.23%|
|Gross profit TTM||$588.8 million|
|Return on assets TTM||6.37%|
|Return on equity TTM||23.46%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
We're not expecting Kraton Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Kraton Corporation's shares have ranged in value from as little as $45.1 up to $46.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Kraton Corporation's is 2.0891. This would suggest that Kraton Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Kraton Corporation manufactures and sells styrenic block copolymers, specialty polymers, and bio-based products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Polymer and Chemical. The Polymer segment offers performance products, including styrene-butadiene-styrene for paving and roofing application; styrene-isoprene-styrene for personal care application; ethylene-vinyl acetate, polyolefins, and metallocene polyolefins for adhesives application; and specialty polymers, such as hydrogenated styrenic block copolymer, isoprene rubber, and isoprene rubber latex for use in medical and personal care products, adhesives, tackifiers, paints, and coatings. The Chemical segment provides pine-based specialty products that include rosin-based tackifiers for packaging and pressure-sensitive adhesive applications; terpene-based tackifiers for bookbinding, hygiene, and pressure-sensitive adhesive applications; alpha-methyl-styrene (AMS) resins; and hot melt polyamides for flexible packaging, industrial and road making applications. This segment also provides tall oil fatty acids, tall oil rosin, distilled tall oil, tall oil pitch, and rosin-based binders for the thermoplastic pavement marking submarket, as well as produces insoluble maleic-based tackifiers. The Chemical segment also offers terpene-based tread enhancement resins and AMS-based tread enhancement additives; and dimer acids and terpene fractions for fuel additives, oilfield chemicals, mining fluids, coatings, metalworking fluids, and lubricants. The company sells its products through various channels, including direct sales force, marketing representatives, and distributors under the Kraton brand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.